Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand

Journal of Acquired Immune Deficiency Syndromes

Volumn 40, Issue 5, 2005, Pages 592-599

  Jenkins, Richard A ^a,b,c,i   Thapinta, Darawan ^d   Morgan, Patricia A ^b,c   Wongkamhaeng, Siriluck ^b,c   Sornsathapornkul, Pornchai ^f   Bussaratid, Valai ^g   Sontirat, Auchara ^e   Pitisuttithum, Punnee ^g   Thongchareoen, Prasert ^f   Khamboonruang, Chirasak ^e,h   Suriyanon, Vinai ^e,h   Nitayaphan, Sorachai ^c   Brown, Arthur E ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d CHIANG MAI UNIVERSITY   (Thailand)

^e Research Institute for Health Sciences   (Thailand)

^f MAHIDOL UNIVERSITY   (Thailand)

^g MAHIDOL UNIVERSITY   (Thailand)

^h Faculty of Medicine Chiang Mai University   (Thailand)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV sexual risk behavior; HIV vaccine trials; Thailand

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; DATA ANALYSIS; DISEASE TRANSMISSION; EMPLOYMENT; FAMILY; FEMALE; FOLLOW UP; FRIEND; HEALTH BEHAVIOR; HEALTH CARE; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SEXUAL BEHAVIOR; SOCIAL ASPECT; SOCIAL PROBLEM; THAILAND;

ADOLESCENT; ADULT; AIDS VACCINES; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HIV-1; HUMANS; MALE; RISK-TAKING; SEXUAL BEHAVIOR; THAILAND; VOLUNTARY WORKERS;

EID: 27944484834     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000171725.09812.a5     Document Type: Article

References (40)

1. Bloom BR. Ethical issues in AIDS vaccine development. AIDS Patient Care STDs. 1999;13:273-279.
2. Cohen J. Shots in the Dark. The Wayward Search for an AIDS Vaccine. New York: WW Norton; 2001.
3. Frey SE. Unique risks to volunteers in HIV vaccine trials. J Investig Med. 2003;51(Suppl 1):S18-S20.
4. Grady C. The Search for an AIDS Vaccine: Ethical Issues in the Development and Testing of a Preventive HIV Vaccine. Bloomington, IN: Indiana University Press; 1995.
5. Gray JN, Lyons PM, Melton GB. Ethical and Legal Issues in AIDS Research. Baltimore: Johns Hopkins University Press; 1995.
6. Kilmarx PH, Ramjee G, Kitayaporn D, et al. Protection of human subjects' rights in HIV-preventive clinical trials in Africa and Asia: experiences and recommendations. AIDS. 2001;15(Suppl 5):73-79.
7. Loue S. Legal and Ethical Aspects of HIV-Related Research. New York: Plenum; 1995.
8. Lurie P, Bishaw M, Chesney MA, et al. Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. JAMA. 1994;271:295-301.
9. Ackers ML, Parekh B, Evans TG, et al. Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients. J Infect Dis. 2003;187:879-886.
10. Sheon AR, Wagner L, McElrath MJ, et al. Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:519-526.
11. Celentano DD, Nelson KE, Beyrer C, et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for the success of the HIV/AIDS control and prevention program. AIDS. 1998;12:F29-F36.
12. Jenkins RA, Temoshok LR, Virochsiri K, et al. Incentives and disincentives to participate in prophylactic HIV vaccine research. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:36-42.
13. Jenkins RA, Torugsa K, Markowitz LE, et al. Willingness to participate in HIV vaccine trials among young Thai men. Sex Transm Infect. 2000;76:386-392.
14. van Griensven F, Keawkungwal J, Tappero JW, et al. Lack of increased HIV risk behavior among injection drug users participating in the AIDSVAX® B/E HIV vaccine trial in Bangkok, Thailand. AIDS. 2004;18:295-301.
15. Thapinta D, Jenkins RA, Morgan PA, et al. Recruiting volunteers for a large phase I/II HIV preventive vaccine trial in Thailand. J Acquir Immune Defic Syndr. 2002;30:503-513.
16. Maek-A-Nantawat W, Pitisuttithum P, Phonrat B, et al. Evaluation of attitude, risk behavior and expectations among Thai participants in phase I/II HIV/AIDS vaccine trials. J Med Assoc Thai. 2003;86:299-307.
17. Phanuphak P, Teeratakulpixarn S, Sarangbin S, et al. International clinical trials of vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand. Asian Pac J Allergy Immunol. 1997;15:41-48.
18. Pitisuttithum P, Migasena S, Laothai A, et al. Risk behaviours and comprehension among intravenous drug users volunteered for HIV vaccine trial. J Med Assoc Thai. 1997;80:47-50.
19. Bartholow BN, Buchbinder S, Celum C, et al. HIV sexual risk behavior over 36 months of follow-up in the world's first HIV vaccine efficacy trial. J Acquir Immune Defic Syndr. 2005;39:90-101.
20. McElrath MJ, Montefiori D, Wolff M, et al. Safety, immunity, and risk behavior in HIV-1 uninfected volunteers representing diverse risk populations following recombinant envelope vaccinations: a three-year follow-up [abstract A284]. Presented at: XI International Conference on AIDS; 1996; Vancouver.
21. Chesney MA, Chambers DB, Kahn JO. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:266-271.
22. Pitisuttithum P, Nitayaphan S, Thongcharoen P, et al. Safety and immunogenicity of combinations of recombinant subtype E and B human immunodeficiency virus type 1 envelope glycoprotein 120 vaccines in healthy Thai adults. J Infect Dis. 2003;188:219-227.
23. Keefer MC, Wolff M, Gorse GJ, et al. Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Development Group. AIDS Res Hum Retroviruses. 1997;13:1163-1177.
24. Nitayaphan S, Khamboonruang C, Sirisophana N, et al. A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative Thais. Vaccine. 1999;18:1448-1455.
25. Thapinta D, Jenkins RA, Celentano DD, et al. Evaluation of behavioral and social issues in Thai HIV vaccine trial volunteers. J Acquir Immune Defic Syndr. 1999;20:308-314.
26. Jenkins RA, Chinaworapong S, Morgan PA, et al. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:171-177.
27. Nelson KE, Celentano DD, Suprasert S, et al. Risk factors for HIV infection among young adult men in Northern Thailand. JAMA. 1993;270:955-960.
28. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297-334.
29. Sittitrai W, Phanuphak P, Barry J, et al. Thai Sexual Behavior and Risk of HIV Infection: a Report of the 1990 Survey of Partner Relations and Risk of HIV Infection in Thailand. Bangkok: Program on AIDS, Thai Red Cross Society; 1992.
30. Thongthai V Guest P. Thai sexual attitudes and behaviour: results from a recent national survey. Presented at: Conference on Gender and Sexuality in Modern Thailand; 1995; Canberra, Australia.
31. Knodel J, Vanlandingham M, Saengtienchai C, et al. Thai views of sexuality and sexual behaviour. Health Transit Rev. 1996;6:179-201.
32. Nelson KE, Eiumtrakul S, Celentano DD, et al. HIV infection in young men in northern Thailand, 1991-98: increasing role of injection drug use. J Acquir Immune Defic Syndr. 2002;29:62-68.
33. Mills S, Benjarattanaporn P, Bennett A, et al. HIV risk behavioral surveillance in Bangkok, Thailand: sexual behavior trends among eight population groups. AIDS. 1997;11(Suppl 1):S43-S51.
34. Catania JA, Gibson DR, Chitwood DD, et al. Methodological problems in AIDS behavioral research: influences on measurement error and participation in studies of sexual behavior. Psychol Bull. 1990;108:339-362.
35. Vanlandingham M, Knodel J, Saengtienchai C, et al. Aren't sexual issues supposed to be sensitive? Health Transit Rev. 1994;4:85-90.
36. Turner CF, Ku L, Rogers SM, et al. Adolescent sexual behavior, drug use, and violence: increased reporting with computer survey technology. Science. 1998;28:867-873.
37. van Griensven F, Supawitkul S, Kilmarx PH, et al. Rapid assessment of sexual behavior, drug use, HIV and sexually transmitted diseases in Northern Thai youth using audio-computer-assisted self-interviewing and non-invasive specimen collection. Pediatrics. 2001;108:E13. Available at: http://pediatrics.aappublications.org/cgi/content/full/108/1/e13?maxtoshow= &HITS=10&hits=10&RESULTFORMAT=&author1=van+griensvenandsearchid= 1091041515634_11427&stored_search=&FIRSTINDEX=0andsortspec= relevance&journalcode=pediatrics.
38. Knodel J, Soottipong R, Saengtienchai C. AIDS Awareness and Knowledge in Thailand: Quantitative and Qualitative Evidence (Population Study Center Publication No. 97-380). Ann Arbor: Population Study Center, University of Michigan; 1997.
39. Celentano DD, Beyrer C, Natpratan C, et al. Willingness to participate in AIDS vaccine trials among high risk populations in northern Thailand. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:1079-1083.
40. Johnson MO. Belief in vaccine receipt in HIV vaccine trials: further cautions. J Acquir Immune Defic Syndr. 1999;21:413-416.